Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62014CN0002

    Case C-2/14: Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 3 January 2014 — Criminal proceedings against Thi Bich Ngoc Nguyen and Nadine Schönherr

    IO C 71, 8.3.2014, p. 12–12 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    8.3.2014   

    EN

    Official Journal of the European Union

    C 71/12


    Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 3 January 2014 — Criminal proceedings against Thi Bich Ngoc Nguyen and Nadine Schönherr

    (Case C-2/14)

    (2014/C 71/20)

    Language of the case: German

    Referring court

    Bundesgerichtshof

    Parties to the main proceedings

    Thi Bich Ngoc Nguyen

    Nadine Schönherr

    Other party to the proceedings: Generalbundesanwalt beim Bundesgerichtshof

    Question referred

    Are medicinal products, as defined in Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, (1) which contain ‘scheduled substances’ listed in Regulations (EC) No 273/2004 (2) and (EC) No 111/2005 (3) always excluded from the scope of those regulations in accordance with Article 2(a) of those regulations, or is that to be presumed only where the medicinal products are compounded in such a way that the scheduled substances cannot for the purposes of those regulations be easily used or extracted by readily applicable or economically viable means?


    (1)  OJ 2001 L 311, p. 67.

    (2)  Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors (OJ 2004 L 47, p. 1).

    (3)  Council Regulation (EC) No 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Community and third countries in drug precursors (OJ 2005 L 22, p. 1).


    Top